175 related articles for article (PubMed ID: 14983939)
1. Primary central nervous system posttransplant lymphoproliferative disorders.
Castellano-Sanchez AA; Li S; Qian J; Lagoo A; Weir E; Brat DJ
Am J Clin Pathol; 2004 Feb; 121(2):246-53. PubMed ID: 14983939
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
[TBL] [Abstract][Full Text] [Related]
3. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
[TBL] [Abstract][Full Text] [Related]
4. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
[TBL] [Abstract][Full Text] [Related]
5. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
Johnson LR; Nalesnik MA; Swerdlow SH
Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
[TBL] [Abstract][Full Text] [Related]
7. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.
Blaes AH; Peterson BA; Bartlett N; Dunn DL; Morrison VA
Cancer; 2005 Oct; 104(8):1661-7. PubMed ID: 16149091
[TBL] [Abstract][Full Text] [Related]
8. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
[TBL] [Abstract][Full Text] [Related]
9. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.
Chen W; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Weiss LM; Wang J
Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621
[TBL] [Abstract][Full Text] [Related]
10. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M
Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
[TBL] [Abstract][Full Text] [Related]
12. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
13. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
Nalesnik MA; Jaffe R; Starzl TE; Demetris AJ; Porter K; Burnham JA; Makowka L; Ho M; Locker J
Am J Pathol; 1988 Oct; 133(1):173-92. PubMed ID: 2845789
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion.
Vakiani E; Nandula SV; Subramaniyam S; Keller CE; Alobeid B; Murty VV; Bhagat G
Hum Pathol; 2007 Feb; 38(2):315-25. PubMed ID: 17134734
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.
Beynet DP; Wee SA; Horwitz SS; Kohler S; Horning S; Hoppe R; Kim YH
Arch Dermatol; 2004 Sep; 140(9):1140-6. PubMed ID: 15381556
[TBL] [Abstract][Full Text] [Related]
17. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
[TBL] [Abstract][Full Text] [Related]
18. Simian virus 40 in posttransplant lymphoproliferative disorders.
Vilchez RA; Jauregui MP; Hsi ED; Novoa-Takara L; Chang CC
Hum Pathol; 2006 Sep; 37(9):1130-6. PubMed ID: 16938517
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphoproliferative disorders of oral cavity.
Ojha J; Islam N; Cohen DM; Marshal D; Reavis MR; Bhattacharyya I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):589-96. PubMed ID: 18442744
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
Capello D; Berra E; Cerri M; Gaidano G
Minerva Med; 2004 Feb; 95(1):53-64. PubMed ID: 15041926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]